Vincristine, Doxorubicin, and Dexamethasone Induction before Autologous Stem Cell Transplantation in Patients with AL Amyloidosis: A Retrospective Comparison with Frontline Stem Cell Transplantation

OBJECTIVE: High-dose melphalan and autologous stem cell transplantation (ASCT) therapy for AL amyloidosis are now associated with reduced mortality based on the application of strict criteria. However, there is no long-term evidence concerning the performance of induction therapy with newer agents,...

Descripción completa

Detalles Bibliográficos
Autores principales: Iijima, Takashi, Sawa, Naoki, Nakayama, Yuki, Oba, Yuki, Ikuma, Daisuke, Mizuno, Hiroki, Yamanouchi, Masayuki, Suwabe, Tatsuya, Wake, Atsushi, Kono, Kei, Hoshino, Junichi, Ubara, Yoshifumi, Ohashi, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593158/
https://www.ncbi.nlm.nih.gov/pubmed/35228429
http://dx.doi.org/10.2169/internalmedicine.9039-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593158/
https://www.ncbi.nlm.nih.gov/pubmed/35228429
http://dx.doi.org/10.2169/internalmedicine.9039-21

Ejemplares similares